Danaher CEO – Tom Joyce (Age – 65)

UPDATE: Thomas P. Joyce, Jr. served as Danaher CEO from September 2014 to September 2020. The current CEO of Danaher Corporation is Rainer M. Blair, who assumed the role on September 1, 2020.

Danaher Corporation (NYSE: DHR), one of the world’s premier science and technology conglomerates, is headquartered in Washington, D.C. Former Danaher CEO Thomas P. Joyce, Jr. (commonly known as Tom Joyce) led the company from September 2014 to September 2020, guiding it through a transformational period that reshaped Danaher from a diversified industrial conglomerate into a focused life sciences and diagnostics powerhouse. During Joyce’s six-year tenure, Danaher delivered shareholder returns three times that of the S&P 500 Index, oversaw more than $50 billion in strategic acquisitions including Pall Corporation, Cepheid, and Cytiva, and spun off two standalone public companies — Fortive Corporation and Envista Holdings. Joyce began his Danaher career in 1989 as a marketing project manager and rose through the ranks over 31 years.

Read on to discover former Danaher CEO Tom Joyce’s email address, net worth in 2026, salary and compensation history, career timeline, wife & family details, and more.
Tom Joyce Danaher CEO
Thomas P. Joyce, Jr., Former President & CEO of Danaher Corporation • Photo: Danaher Corporation

Tom Joyce – Quick Facts

Thomas P. Joyce, Jr. — At a Glance
Full Name Thomas Patrick Joyce, Jr.
Position Former President & Chief Executive Officer
Company Danaher Corporation (NYSE: DHR)
Age ~65 years (born c. 1960; Class of 1982)
Education B.A. in Economics, College of the Holy Cross (1982)
Net Worth (Est. 2026) $150–200 Million
Final Compensation (FY2020) ~$17 Million
CEO Tenure September 2014 – September 2020
Current Role Board Director, Roper Technologies; Senior Advisor, BayPine
Email [email protected] (former)
Hometown Washington, D.C. (raised in Chicago)

Danaher Corporation Competitors

Danaher Corporation competes in the global life sciences, biotechnology, and diagnostics industries. The key competitors of Danaher include:

  • Thermo Fisher Scientific – the world’s largest life sciences instrumentation company
  • Abbott Laboratories – diversified medical devices and diagnostics
  • Roche Diagnostics (Roche Holding AG) – global leader in in-vitro diagnostics
  • Siemens Healthineers – medical imaging and diagnostics
  • Agilent Technologies – life sciences and analytical instruments
  • Revvity (formerly PerkinElmer) – diagnostics and life sciences
  • Bio-Rad Laboratories – life science research and diagnostics
  • Illumina – genomics and DNA sequencing

Tom Joyce Net Worth 2026 – Danaher CEO Salary

As of 2026, Tom Joyce’s net worth is estimated at approximately $150–200 million, accumulated over his 31-year career at Danaher Corporation. According to an Equilar analysis, Joyce realized over $162 million in total compensation during his time at Danaher (from 2007 through his retirement in 2020), including salary, bonuses, stock awards, and option exercises. Joyce also holds board positions at Roper Technologies (NYSE: ROP) and serves as a senior advisor at BayPine, a private equity firm.

Danaher CEO Compensation Breakdown (FY2020 – Final Year)

Component Amount (USD) Share
Base Salary $1,400,000 8.2%
Non-Equity Incentive (Bonus) $3,100,000 18.2%
Stock Awards $6,300,000 37.1%
Option Awards $5,500,000 32.4%
Other Compensation $700,000 4.1%
TOTAL ~$17,000,000 100%

Tom Joyce – Historical Compensation at Danaher

Fiscal Year Total Compensation YoY Change
FY2020 (Final Year) ~$17.0M ▼ 8%
FY2019 ~$18.0M ▲ 18%
FY2018 ~$15.3M
FY2017 ~$14.8M
Key Insight: Over 91.8% of Tom Joyce’s FY2020 compensation was performance-based (bonus + equity), with only 8.2% from base salary. According to Equilar, Joyce realized over $162 million in total compensation from Danaher between 2007 and his 2020 retirement — one of the highest total payouts for a conglomerate CEO.

Danaher Net Worth 2026 – Is Danaher Profitable?

Yes, Danaher Corporation is a highly profitable company. With a market capitalization of approximately $150 billion as of early 2026, Danaher is one of the most valuable life sciences and diagnostics companies in the world.

Danaher Corporation Financial Summary (FY2025)

Metric Value YoY Change
Market Capitalization ~$150B
Annual Revenue $24.6B ▲ 2.9%
Net Income $3.6B ▼ 7.3%
Gross Margin ~59.5%
Operating Cash Flow $6.4B
Adj. EPS $7.80 ▲ 4.5%
Employees ~79,000+
NYSE Ticker DHR
Growth Under Joyce: During Tom Joyce’s CEO tenure (2014–2020), Danaher’s stock price more than tripled, delivering shareholder returns three times the S&P 500 Index. Joyce oversaw the transformational $21.4 billion acquisition of GE Biopharma (rebranded as Cytiva) and the strategic spinoffs of Fortive and Envista.

Danaher CEO Email Address | Tom Joyce Contact

Below are the contact details and corporate information for former Danaher CEO Tom Joyce. Note that Joyce retired from Danaher in September 2020:

Contact Information
Email Address (Former) [email protected]
Current CEO Email [email protected]
Corporate HQ 2200 Pennsylvania Ave NW, Washington, DC 20037
Phone (202) 828-0850
Website www.danaher.com
Investor Relations investors.danaher.com

Career & Education – Company, University, & College

Thomas P. Joyce, Jr. spent over three decades at Danaher Corporation, rising from a marketing project manager to President and CEO. Below is his complete career timeline:

Tom Joyce Career Timeline

Period Role Company
1982–1989 Senior Manager, Manufacturing & Distribution Practice Andersen Consulting
1989–1995 Marketing Project Manager → Manufacturing & Marketing Roles Danaher (Hand Tool Group)
1995–2001 President, Delta Consolidated Industries Danaher
2001–2002 President, Hach Company Danaher
2002–2006 Group Executive & Corporate Officer Danaher Corporation
2006–2014 Executive Vice President ($9B+ portfolio: Life Sciences, Diagnostics, Water Quality) Danaher Corporation
2014–2020 President & Chief Executive Officer Danaher Corporation
2020–2021 Senior Advisor Danaher Corporation
2021–Present Board of Directors; Senior Advisor, BayPine Roper Technologies; BayPine

Before joining Danaher, Tom Joyce spent seven years at Andersen Consulting (now Accenture), where he rose to Senior Manager in the manufacturing and distribution practice. He joined Danaher in 1989 as a Marketing Project Manager in the Danaher Tool Group, following Danaher’s acquisition of Easco Hand Tools in 1990.

Over the next decade, Joyce held progressively senior marketing and manufacturing roles before becoming President of Delta Consolidated Industries in 1995 and then President of Hach Company — a global leader in water analytics — in 2001. He was appointed a Group Executive and Corporate Officer in 2002, and elected Executive Vice President in 2006.

As EVP, Joyce oversaw more than $9 billion in annual revenues across Danaher’s Life Sciences & Diagnostics and Water Quality businesses. He led the landmark acquisitions of Beckman Coulter and AB SCIEX, growing the Water Quality platform’s revenue by over $1.5 billion. Upon becoming CEO in September 2014, he succeeded H. Lawrence Culp, Jr. and continued Danaher’s legendary acquisition-driven growth strategy.

Education

University Degree / Program Website
College of the Holy Cross Bachelor of Arts in Economics (Class of 1982) holycross.edu
Tom Joyce former Danaher CEO
Tom Joyce led Danaher Corporation through a transformational era from 2014 to 2020 • Photo: Danaher Corporation

Tom Joyce Wiki – Age, Wife, Family, & More

Former Danaher CEO Tom Joyce (age approximately 65 as of 2026) was born and raised on the north shore of Chicago, Illinois. He and his wife, Claire, have four children. The family resides in Washington, D.C., where Danaher Corporation is headquartered.

Notable Achievements & Board Memberships

  • Danaher Business System Architect – Played a key role in developing and evolving DBS, Danaher’s renowned continuous improvement methodology
  • $50B+ in Acquisitions – Led the acquisitions of Pall Corporation, Cepheid, IDT, and the $21.4B GE Biopharma deal (Cytiva)
  • Created Two Public Companies – Oversaw the spinoffs of Fortive Corporation (2016) and Envista Holdings (2019)
  • Roper Technologies Board – Elected to the Board of Directors in October 2021
  • BayPine Senior Advisor – Senior advisor to the Boston-based private investment firm
  • College of the Holy Cross Board – Serves on the board of his alma mater
  • MedStar Health Board – Board member of the Washington, D.C.-area healthcare system
  • Charter School Growth Fund – Board involvement supporting education
  • Economic Club of Washington – Member and speaker

Joyce is known for his deep commitment to the Danaher Business System (DBS) — the company’s proprietary toolset for customer-centric continuous improvement — and for his belief in building organizations around a “shared purpose” and the mission of “helping realize life’s potential.”

About Danaher Corporation

Danaher Corporation is an American global science and technology conglomerate headquartered in Washington, D.C. Founded in 1984 by brothers Steven Rales and Mitchell Rales — and named after Danaher Creek in Western Montana where they conceived the idea — the company has grown into one of the world’s most valuable healthcare and life sciences companies with a market capitalization of approximately $150 billion.

Danaher operates through three business segments encompassing more than 15 operating companies:

Segment % of Revenue Key Brands
Biotechnology 28% Cytiva, Pall Corporation
Life Sciences 31% Beckman Coulter, Leica Microsystems, SCIEX, IDT, Abcam
Diagnostics 41% Cepheid, Leica Biosystems, Beckman Coulter Diagnostics

Danaher trades on the New York Stock Exchange under the ticker symbol DHR. The company employs approximately 79,000+ people worldwide and reported $24.6 billion in revenue for fiscal year 2025. In early 2026, Danaher announced a $9.9 billion agreement to acquire Masimo Corporation, which is expected to close in the second half of 2026.

Frequently Asked Questions (FAQ)

Who is the current CEO of Danaher Corporation?

The current CEO of Danaher Corporation is Rainer M. Blair, who was appointed President and Chief Executive Officer on September 1, 2020. Blair succeeded Thomas P. Joyce, Jr., who had served as CEO since September 2014. Tom Joyce transitioned to a Senior Advisor role before fully retiring in February 2021.

What is Tom Joyce’s net worth in 2026?

As of 2026, Tom Joyce’s net worth is estimated at approximately $150–200 million. This estimate is based on over $162 million in total realized compensation from Danaher (2007–2020), including salary, bonuses, stock awards, and option exercises, as well as his ongoing board compensation from Roper Technologies and advisory fees from BayPine.

What was Danaher CEO Tom Joyce’s salary?

In his final year as CEO (FY2020), Tom Joyce’s total compensation was approximately $17 million, comprising a $1.4 million base salary, $3.1 million bonus, $6.3 million in stock awards, $5.5 million in option awards, and approximately $700,000 in other compensation. His peak year was FY2019 at roughly $18 million in total compensation.

What is Danaher CEO’s email address?

Former Danaher CEO Tom Joyce’s email address was [email protected]. The current CEO, Rainer M. Blair, can be reached at [email protected]. Danaher’s corporate headquarters can be contacted at (202) 828-0850 at 2200 Pennsylvania Ave NW, Washington, DC 20037.

What did Tom Joyce do before becoming Danaher CEO?

Tom Joyce spent seven years at Andersen Consulting (now Accenture) before joining Danaher in 1989. Over 25 years, he held roles including Marketing Project Manager, President of Delta Consolidated Industries, President of Hach Company, Group Executive, and Executive Vice President overseeing $9 billion+ in annual revenues across Life Sciences, Diagnostics, and Water Quality before becoming CEO in September 2014.

Is Danaher Corporation profitable?

Yes, Danaher is highly profitable. In fiscal year 2025, the company reported revenue of $24.6 billion and net income of $3.6 billion. The company generated $6.4 billion in operating cash flow with gross margins of approximately 59.5%. Danaher has a market capitalization of approximately $150 billion and is guiding for 3–6% core revenue growth in 2026.

Article last updated:February 2026March 2, 2026

Disclaimer: All information presented in this article has been compiled from publicly available sources, including SEC filings (DEF 14A proxy statements), official Danaher Corporation press releases, and reputable news outlets. Net worth figures are estimates based on disclosed compensation and may vary by source. This content is provided for informational purposes only and does not constitute financial or investment advice.